International survey to investigate the implementation of daily ICU care for patients with and without COVID-19 infection. A Point Prevalence Study -ISIIC 2 Study

Recruitment & Eligibility

Status: Complete: follow-up complete

Sex: All

Target Recruitment: 1229

Inclusion Criteria

Not provided

Exclusion Criteria

patients in a terminal state and receiving palliative care

Study & Design

Study Type: Observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The implementation rate of the ABCDEF bundle as each element or an entire of the bindle

Secondary Outcome Measures

Name	Time	Method

Related Trials

International survey to investigate the implementation of ICU daily care for COVID-19

Not Applicable

The Prince Charles Hospital

Updated 10/17/2023

A survey study based on international consensus building for the development and further improvement of medical guidelines for Castleman's disease, TAFRO syndrome and related diseases; RADDAR-J[77]

RecruitingNot Applicable

Ministry of Health, Labour and Welfare

Updated 10/17/2023

International survey on the present status of integrative medicine and the approach for it.

Not Applicable

MOA Health Science Foundation, the general incorporated foundation

Updated 10/17/2023

INternational observational study To Understand current practices for managing the respiratory support in critically ill patients

Not Applicable

on funded project

Updated 11/24/2021

International and observational study to understand the impact and best practices of treatment of a set of maneuvers and medical procedures performed to prevent and relieve airway obstruction in terminal ill patients.

Not Applicable

niversity Hospital San Gerardo

Updated 11/24/2021

Study in several countries to assess the proportion of adult women (25-45 yrs) who accept to receive the HPV vaccine, the reasons to accept it and how many of these women receive the three doses and why.

Phase 1

Ghent University Hospital

Updated 11/25/2019

Study in several countries to assess the proportion of adult women (25-45 yrs) who accept to receive the HPV vaccine, the reasons to accept it and how many of these women receive the three doses and why.

Phase 1

Catalan Institute of Oncology

Updated 4/30/2019

Study in several countries to assess the proportion of adult women (25-45 yrs) who accept to receive the HPV vaccine, the reasons to accept it and how many of these women receive the three doses and why.

Phase 1

Catalan Institute of Oncology

Updated 4/5/2021

Study in several countries to assess the proportion of adult women (25-45 yrs) who accept to receive the HPV vaccine, the reasons to accept it and how many of these women receive the three doses and why.

Phase 1

Catalan Institute of Oncology

Updated 8/20/2018

Study in several countries to assess the proportion of adult women (25-45 yrs) who accept to receive the HPV vaccine, the reasons to accept it and how many of these women receive the three doses and why.

Phase 1

Catalan Institute of Oncology

Updated 4/19/2022

International survey to investigate the implementation of daily ICU care for patients with and without COVID-19 infection. A Point Prevalence Study -ISIIC 2 Study

Recruitment & Eligibility

Study & Design

Related Trials

International survey to investigate the implementation of ICU daily care for COVID-19

A survey study based on international consensus building for the development and further improvement of medical guidelines for Castleman's disease, TAFRO syndrome and related diseases; RADDAR-J[77]

International survey on the present status of integrative medicine and the approach for it.

INternational observational study To Understand current practices for managing the respiratory support in critically ill patients

International and observational study to understand the impact and best practices of treatment of a set of maneuvers and medical procedures performed to prevent and relieve airway obstruction in terminal ill patients.

Study in several countries to assess the proportion of adult women (25-45 yrs) who accept to receive the HPV vaccine, the reasons to accept it and how many of these women receive the three doses and why.

Study in several countries to assess the proportion of adult women (25-45 yrs) who accept to receive the HPV vaccine, the reasons to accept it and how many of these women receive the three doses and why.

Study in several countries to assess the proportion of adult women (25-45 yrs) who accept to receive the HPV vaccine, the reasons to accept it and how many of these women receive the three doses and why.

Study in several countries to assess the proportion of adult women (25-45 yrs) who accept to receive the HPV vaccine, the reasons to accept it and how many of these women receive the three doses and why.

Study in several countries to assess the proportion of adult women (25-45 yrs) who accept to receive the HPV vaccine, the reasons to accept it and how many of these women receive the three doses and why.

Clinical Trial Alerts

Clinical Trial Alerts

International survey to investigate the implementation of daily ICU care for patients with and without COVID-19 infection. A Point Prevalence Study -ISIIC 2 Study

Recruitment & Eligibility

Study & Design

Related Trials

International survey to investigate the implementation of ICU daily care for COVID-19

A survey study based on international consensus building for the development and further improvement of medical guidelines for Castleman&#39;s disease, TAFRO syndrome and related diseases; RADDAR-J[77]

International survey on the present status of integrative medicine and the approach for it.

INternational observational study To Understand current practices for managing the respiratory support in critically ill patients

International and observational study to understand the impact and best practices of treatment of a set of maneuvers and medical procedures performed to prevent and relieve airway obstruction in terminal ill patients.

Study in several countries to assess the proportion of adult women (25-45 yrs) who accept to receive the HPV vaccine, the reasons to accept it and how many of these women receive the three doses and why.

Study in several countries to assess the proportion of adult women (25-45 yrs) who accept to receive the HPV vaccine, the reasons to accept it and how many of these women receive the three doses and why.

Study in several countries to assess the proportion of adult women (25-45 yrs) who accept to receive the HPV vaccine, the reasons to accept it and how many of these women receive the three doses and why.

Study in several countries to assess the proportion of adult women (25-45 yrs) who accept to receive the HPV vaccine, the reasons to accept it and how many of these women receive the three doses and why.

Study in several countries to assess the proportion of adult women (25-45 yrs) who accept to receive the HPV vaccine, the reasons to accept it and how many of these women receive the three doses and why.

Clinical Trial Alerts

Clinical Trial Alerts

A survey study based on international consensus building for the development and further improvement of medical guidelines for Castleman's disease, TAFRO syndrome and related diseases; RADDAR-J[77]